Exercise still trumps pharmaceutical interventions for CRF relief

Recent studies show the evidence continues to support exercise and holistic measures as the most effective intervention for cancer-related fatigue.

Genomics vs genetics: How are they different?

This overview offers a simple guide for explaining to patients the difference between the terms, the tests, and what the results may mean.

Answering the unanswerable

Sometimes the best answer to a patient's question is quiet support. Can you recognize when no words are needed?

U.S. health care expenditure growth has slowed

The growth in U.S. health care expenditure has slowed in recent years, coming some way toward closing the gap with other countries.

Specialized apps extend the reach of community

It may be small, but the smartphone is becoming a tremendous asset for the care of cancer survivors by means of specialized apps.

Complementary and alternative medicine

Have you visited our new section dedicated to biologic treatments, body-based practices, mind-body methods, and alternate medical systems?

Features

Issues in Cancer Survivorship

Growing evidence of coffee's cancer-preventive properties

Can one of the most popular beverages in the world limit or even prevent the growth of certain cancers?

Videos

Latest News

More than 40 melanoma-specific genes determine disease aggressiveness

Researchers have discovered more than 40 genes that predict the level of aggressiveness of melanoma and that distinguish it from other cancers with a poor prognosis.

HIV-positive patients are more likely to be untreated for early-stage cancer

HIV-infected people with early stage cancer are two to four times more likely to go untreated for their cancer compared to uninfected patients with cancer, according to a new, large retrospective study.

Genetics is the dominant risk factor for familial breast, prostate, and colorectal cancers

A study of people who were adopted identified genetics as the dominant risk factor in familial breast, prostate, and colorectal cancers.

Novel approach reduces risk of cervical cancer

Researchers describe a novel approach to preventing cervical cancer. The study findings showed a reduction in cervical cancer risk after removal of a discrete population of cervical cells called squamocolumnar junction cells.

Full Explanation Reduces Seniors' Anxiety about Lung Cancer Screening

A new study of participants in the NLST found evidence that men and women age 55 to 74 who had an abnormal finding on a lung cancer screening test did not experience more anxiety or reduced quality of life than did those who were screened and found to be cancer-free.

Idelalisib approved by FDA for three types of blood cancer

Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, but label warns drug may be toxic to the liver.

Fact Sheets

Antioxidants and Cancer Prevention (Fact Sheet)

Antioxidants and Cancer Prevention (Fact Sheet)

This fact sheet explores possible relationships between antioxidants and cancer prevention.

Asbestos Exposure and Cancer Risk (Fact Sheet)

Asbestos Exposure and Cancer Risk (Fact Sheet)

This fact sheet defines asbestos, and reviews both the use of asbestos and health risks associated with asbestos exposure.

Editorial Board

Ann J. Brady, MSN, RN-BC

Jia Conway, DNP, FNP-BC, AOCNP, NP-C

Michele M. Farrington, BSN, RN, CPHON

Donald R. Fleming, MD

Arati Jairam-Thodla, MSN, CNP

Karen MacDonald, RN, BSN, CPON

Marlene McGuire, RN, MA, ANP-C

Kerstin L. McSteen, BSN, MSN, ACHPN, CNS-BC

Helen H. Miller, LCSW, ACSW

Maribel Pereiras, PharmD, BCPS, BCOP

Leah A. Scaramuzzo, MSN, RN-BC, AOCN

Lisa A. Thompson, PharmD, BCOP

Rosemarie A. Tucci, RN, MSN, AOCN

     .

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs